← Browse by Condition
Medical Condition
autosomal dominant polycystic kidney disease
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 3, Phase 2
NCT04344769
Recruiting
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Enrollment
40 pts
Location
United States
Sponsor
Mayo Clinic
NCT04939935 Phase 3
Recruiting
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Enrollment
1,174 pts
Location
Australia, New Zeala...
Sponsor
The University of Queensland
NCT06065852
Recruiting
National Registry of Rare Kidney Diseases
Enrollment
35,000 pts
Location
United Kingdom
Sponsor
UK Kidney Association
NCT06902558 Phase 2
Recruiting
A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Enrollment
240 pts
Location
United States, Austr...
Sponsor
AbbVie